JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Fiverr International Ltd. (FVRR) PT Raised to $67 at JMP Securities
-
JMP Securities Upgrades Cree (CREE) to Market Outperform
-
JMP Securities Downgrades Capitala Finance (CPTA) to Market Perform
-
Poxel Successfully Raises €17.7 Million in a Capital Increase
-
Gamida Cell Ltd. (GMDA) PT Lowered to $17 at JMP Securities, Following Earnings
-
Couchbase Announces $105 Million Equity Investment Led by GPI Capital to Fuel Its Next Phase of Growth and Cloud Innovation
-
Couchbase Announces $105 Million Equity Investment Led by GPI Capital to Fuel Its Next Phase of Growth and Cloud Innovation
-
Ocular Therapeutix (OCUL) Prices 8.2M Share Offering of Common Stock at $5.50/sh
-
Ocular Therapeutix™ Announces Pricing of Public Offering of Common Stock
-
RealPage (RP) Prices 5.085M Share Common Offering at $59/Sh; Announces Pricing of $300M Convertible Senior Notes Due 2025
-
RealPage Prices Offerings of Common Stock and Convertible Senior Notes
-
Kount Is Named to JMP Elite 80 List for 2020’s Hottest Privately Held Cybersecurity and IT Infrastructure Companies
-
Tesla (TSLA) PT Lowered to $1,001 at JMP Securities Due to Capacity Constraints at Freemont
-
Gamida Cell Ltd. (GMDA) Prices 13.334M Share Common Offering at $4.50/Sh
-
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
-
Gamida Cell Ltd. (GMDA) Announces Launch of Proposed Public Offering of Ordinary Shares
-
Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares
-
UPDATE: JMP Securities Resumes PLx Pharma (PLXP) at Market Outperform
-
Pre-Open Movers 05/15: (SRNE) (NEWR) (DENN) Higher; (SAVA) (JCP) (CODX) Lower (more...)
-
UPDATE: JMP Securities Starts Baudax Bio Inc. (BXRX) at Market Outperform
-
Actifio Records Strongest Q1 in Company History as Customers Flock to Cost Savings, Cyber Resilience, Digital Business Enablers
-
Demandbase Launches The ABM Innovation Tour
-
Kiniksa Pharmaceuticals Ltd. (KNSA) Prices 2.4M Class A Share Common Offering at $18.25/Sh
-
Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Public Offering
-
Kiniksa Pharmaceuticals Ltd. (KNSA) Announces Proposed 1.8M Class A Share Common Offering
-
Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering
-
Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering
-
Upwork Inc. (UPWK) PT Raised to $16 at JMP Securities
-
Heritage to Participate in JMP Securities Virtual Insurance Forum on May 14th
-
Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
-
Insmed Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Peloton Interactive (PTON) PT Raised to $53 at JMP Securities as Revenue Drivers Outperform
-
Kura Oncology (KURA) Prices 9.1M Common Stock Offering at $13.75/Share
-
Kura Oncology Announces Pricing of $125 Million Public Offering of Common Stock
-
WorkRamp Recognized as a Leader on the JMP Hot 100 and Releases New Features to Accelerate Digital Transformation
-
Insmed (INSM) Prices 9.7M Common Stock Offering at $23.25/sh
-
LogicMonitor Extends Global Channel Reach with New International Partners
-
RedSeal’s Cyber Terrain Analytics Platform Lauded Across Verticals with Seven Awards for Excellence
-
Insmed Announces Pricing of Public Offering of Common Stock
-
Sensor Tower Secures $45M and Partners With Riverwood Capital to Fuel Growth
-
Tesla (TSLA) PT Raised to $1,020 at JMP Securities on Multiple Expansion to Pre-COVID Levels
-
Peloton Interactive (PTON) PT Raised to $43 at JMP Securities As Engagement Reaches All Time Highs
-
JMP Group Reports First Quarter 2020 Financial Results
-
resTORbio (TORC) and Adicet Bio Announce Merger Agreement
-
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
-
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
-
Tesla (TSLA) May Emerge Stronger From the Slowdown - JMP Securities
-
Kiniksa (KNSA) PT Raised to $40 at JMP Securities, After Company Announces Phase 2 Clinical Trial Of Vixarelimab (KPL-716) In Prurigo Nodularis Meets Primary Efficacy Endpoint
-
Applied Molecular Transport Appoints Industry Veteran Shawn Cross as Chief Financial Officer and Promotes Bittoo Kanwar, M.D. to Chief Medical Officer
-
Applied Molecular Transport Appoints Industry Veteran Shawn Cross as Chief Financial Officer and Promotes Bittoo Kanwar, M.D. to Chief Medical Officer

